Diabetes Care

Papers
(The H4-Index of Diabetes Care is 80. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
2. Classification and Diagnosis of Diabetes:Standards of Medical Care in Diabetes—20211843
2. Classification and Diagnosis of Diabetes:Standards of Medical Care in Diabetes—20221322
2. Classification and Diagnosis of Diabetes:Standards of Care in Diabetes—20231005
Social Determinants of Health and Diabetes: A Scientific Review750
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2021733
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)638
6. Glycemic Targets: Standards of Medical Care in Diabetes—2021580
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2022548
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2023491
6. Glycemic Targets: Standards of Medical Care in Diabetes—2022439
10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2021348
6. Glycemic Targets: Standards of Care in Diabetes—2023306
The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)305
10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2022285
Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)249
Introduction: Standards of Medical Care in Diabetes—2022242
10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023240
11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2021238
2. Diagnosis and Classification of Diabetes:Standards of Care in Diabetes—2024232
5. Facilitating Behavior Change and Well-being to Improve Health Outcomes:Standards of Medical Care in Diabetes—2021217
Etiology, Epidemiology, and Disparities in the Burden of Diabetic Foot Ulcers212
Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes203
COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic’s Impact in Type 1 and Type 2 Diabetes198
Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening196
COVID-19, Hyperglycemia, and New-Onset Diabetes195
5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes:Standards of Care in Diabetes—2023189
Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study188
5. Facilitating Behavior Change and Well-being to Improve Health Outcomes:Standards of Medical Care in Diabetes—2022182
14. Management of Diabetes in Pregnancy:Standards of Medical Care in Diabetes—2021171
11. Chronic Kidney Disease and Risk Management: Standards of Medical Care in Diabetes—2022170
7. Diabetes Technology: Standards of Care in Diabetes—2023170
Improved Glycemic Outcomes With Medtronic MiniMed Advanced Hybrid Closed-Loop Delivery: Results From a Randomized Crossover Trial Comparing Automated Insulin Delivery With Predictive Low Glucose Suspe167
7. Diabetes Technology: Standards of Medical Care in Diabetes—2022167
7. Diabetes Technology: Standards of Medical Care in Diabetes—2021162
Introduction: Standards of Medical Care in Diabetes—2021162
Heart Failure: An Underappreciated Complication of Diabetes. A Consensus Report of the American Diabetes Association156
13. Children and Adolescents: Standards of Medical Care in Diabetes—2021151
11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2023149
12. Older Adults:Standards of Medical Care in Diabetes—2021148
Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes147
15. Management of Diabetes in Pregnancy:Standards of Medical Care in Diabetes—2022142
3. Prevention or Delay of Type 2 Diabetes:Standards of Medical Care in Diabetes—2021140
8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes:Standards of Medical Care in Diabetes—2022139
Worldwide Epidemiology of Diabetes-Related End-Stage Renal Disease, 2000–2015138
15. Management of Diabetes in Pregnancy:Standards of Care in Diabetes—2023134
15. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2021132
16. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2022131
13. Older Adults: Standards of Medical Care in Diabetes—2022127
Metabolomics and Type 2 Diabetes Risk: An Updated Systematic Review and Meta-analysis of Prospective Cohort Studies123
8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes—2023123
High Prevalence of Advanced Liver Fibrosis Assessed by Transient Elastography Among U.S. Adults With Type 2 Diabetes115
Association of Serum 25-Hydroxyvitamin D Concentrations With All-Cause and Cause-Specific Mortality Among Individuals With Diabetes114
14. Children and Adolescents: Standards of Medical Care in Diabetes—2022112
Association of a Healthy Lifestyle With All-Cause and Cause-Specific Mortality Among Individuals With Type 2 Diabetes: A Prospective Study in UK Biobank112
4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2021110
Global Prevalence of Prediabetes110
8. Obesity Management for the Treatment of Type 2 Diabetes:Standards of Medical Care in Diabetes—2021109
14. Children and Adolescents: Standards of Care in Diabetes—2023108
Metformin Affects Gut Microbiome Composition and Function and Circulating Short-Chain Fatty Acids: A Randomized Trial108
Introduction and Methodology: Standards of Care in Diabetes—2023107
Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11)105
16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2023104
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2024102
13. Older Adults: Standards of Care in Diabetes—2023102
12. Retinopathy, Neuropathy, and Foot Care: Standards of Medical Care in Diabetes—202299
Adult-Onset Type 1 Diabetes: Current Understanding and Challenges97
4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—202296
Multicenter, Head-to-Head, Real-World Validation Study of Seven Automated Artificial Intelligence Diabetic Retinopathy Screening Systems93
4. Comprehensive Medical Evaluation and Assessment of Comorbidities:Standards of Care in Diabetes—202391
GLP-1 Receptor Agonists and the Risk of Thyroid Cancer91
Economic Costs of Diabetes in the U.S. in 202290
Interpretable Machine Learning Framework Reveals Robust Gut Microbiome Features Associated With Type 2 Diabetes90
Plasma Vitamin C and Type 2 Diabetes: Genome-Wide Association Study and Mendelian Randomization Analysis in European Populations88
3. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes—202388
Incidence of Type 1 Diabetes in Children and Adolescents During the COVID-19 Pandemic in Germany: Results From the DPV Registry85
1. Improving Care and Promoting Health in Populations: Standards of Care in Diabetes—202383
Summary of Revisions: Standards of Care in Diabetes—202383
12. Retinopathy, Neuropathy, and Foot Care:Standards of Care in Diabetes—202383
Associations of Serum Carotenoids With Risk of Cardiovascular Mortality Among Individuals With Type 2 Diabetes: Results From NHANES82
Effects of Vitamin C Supplementation on Glycemic Control and Cardiovascular Risk Factors in People With Type 2 Diabetes: A GRADE-Assessed Systematic Review and Meta-analysis of Randomized Controlled T81
Accuracy of Dexcom G6 Continuous Glucose Monitoring in Non–Critically Ill Hospitalized Patients With Diabetes80
0.047001838684082